Drug interactions
Encorafenib + Saxagliptin-metformin
Severity: Moderate
Encorafenib and Saxagliptin-metformin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Encorafenib can both inhibit and induce CYP3A4, so saxagliptin exposure may rise or fall. The net effect is unpredictable, and glycemic control may be affected.
What this interaction means in plain words
Encorafenib and Saxagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Encorafenib belongs to Oncology; Saxagliptin-metformin belongs to Endocrine.
Why it happens
Encorafenib exerts mixed CYP3A4 inhibition and induction, altering saxagliptin metabolism unpredictably.
What to do
Monitor blood glucose and HbA1c during encorafenib therapy. Adjust the antidiabetic regimen according to response.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Saxagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Saxagliptin-metformin
Other interactions of Encorafenib
Frequently asked questions
Can I take Encorafenib with Saxagliptin-metformin?
MediHelp rates the interaction as moderate. Encorafenib and Saxagliptin-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Encorafenib can both inhibit and induce CYP3A4, so saxagliptin exposure may rise or fall. The net effect is unpredictable, and glycemic control may be affected.
How serious is the interaction between Encorafenib and Saxagliptin-metformin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c during encorafenib therapy. Adjust the antidiabetic regimen according to response.
What other medicines interact with Saxagliptin-metformin?
MediHelp also lists interactions of Saxagliptin-metformin with, for example, Atazanavir, Clozapine, Contrast media. The full list is on the Saxagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
